Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avid Bioservices, Inc. - Common Stock (NQ: CDMO )

12.49 UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avid Bioservices, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Earnings Scheduled For June 21, 2023
Companies Reporting Before The Bell • iHuman (NYSE:IH) is projected to report earnings for its first quarter. 
Via Benzinga
Earnings Preview For Avid Bioservices
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Dow Extends Rebound, Surges 456 Points
Rallying bank stocks are fueling Wall Street's midday gains, as investors continue to unpack this morning's consumer price index (CPI) data. 
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Avid Bioservices Inc. (NASDAQ: CDMO) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
Why Avid Bioservices Stock Is Surging Today
The bio-manufacturer's ongoing expansion efforts are a hit with investors. 
Via The Motley Fool
Avid Bioservices Earnings Preview
Via Benzinga
Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
Avid Bioservices Inc. (NASDAQ: CDMO) is a contract development and manufacturing organization (CDMO) that specializes in producing monoclonal antibodies, 
Via MarketBeat
Exposures COVID-19
Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Ainos, Inc. (NASDAQ: AIMD) shares jumped 69.3% to $1.27 after the company announced it signed a Memorandum of Understanding with Merdury Biopharmaceutical to jointly explore and develop a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
Via Benzinga
First Republic Bank, PacWest Bancorp, Western Alliance Bancorporation And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Nasdaq Composite gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
United Natural Foods, Ollie's Bargain, Smith & Wesson Brands And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded mostly lower, with the Nasdaq Composite dropping over 60 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Read How Avid Bioservices Fared In Q4
Via Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC... 
Via Benzinga
Earnings Scheduled For December 6, 2022
Companies Reporting Before The Bell • AutoZone (NYSE:AZO) is projected to report quarterly earnings at $25.27 per share on revenue of $3.86 billion. 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Wednesday, 10/19, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Avid Bioservices Earnings Perspective: Return On Invested Capital
According to Benzinga Pro data Avid Bioservices (NASDAQ:CDMO) posted a 98.65% decrease in earnings from Q4. Sales, however, increased by 17.5% over the previous quarter to $36.69 million. 
Via Benzinga
Earnings Scheduled For September 6, 2022
Companies Reporting Before The Bell • LightInTheBox Holding (NYSE:LITB) is expected to report earnings for its second quarter. 
Via Benzinga
Looking Into Avid Bioservices's Return On Capital Employed
According to Benzinga Pro, during Q4, Avid Bioservices (NASDAQ:CDMO) earned $115.60 million, a 5042.26% increase from the preceding quarter. Avid Bioservices's sales decreased to $31.23 million, a 0.9%... 
Via Benzinga
Earnings Scheduled For June 29, 2022
Companies Reporting Before The Bell • MSC Industrial Direct Co (NYSE:MSM) is expected to report quarterly earnings at $1.74 per share on revenue of $960.52 million. 
Via Benzinga
Avid Bioservices's Earnings Outlook
Avid Bioservices (NASDAQ:CDMO) is set to give its latest quarterly earnings report on Wednesday, 2022-06-29. Here's what investors need to know before the announcement. Analysts estimate that Avid... 
Via Benzinga
7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years
Finding micro-cap stocks to buy requires a bit of everything, including patience. Today's plan is to pick from the top of the IWC ETF. 
Via InvestorPlace
Avid Bioservices's Return On Capital Employed Overview
Pulled from Benzinga Pro data, Avid Bioservices (NASDAQ:CDMO) showed a loss in earnings since Q2, totaling $2.25 million. Sales, on the other hand, increased by 20.68% to $31.51... 
Via Benzinga
Recap: Avid Bioservices Q3 Earnings
Avid Bioservices (NASDAQ:CDMO) reported its Q3 earnings results on Tuesday, March 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Avid... 
Via Benzinga
Avid Bioservices's Earnings: A Preview
Avid Bioservices (NASDAQ:CDMO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
How Bad Are Avid Bioservices's Earnings? | Return On Capital Employed
According to Benzinga Pro, during Q2, Avid Bioservices (NASDAQ:CDMO) earned $4.15 million, a 40.08% increase from the preceding quarter. Avid Bioservices's sales decreased to $26.... 
Via Benzinga
Earnings Scheduled For March 8, 2022
Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.